Form 4 for EQ Equillium, Inc.
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-16 · accession 0001209191-21-065041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-17 | 2021-11-16 | EQ | Zedelmayer Christine | COO, Sr. VP | M - OptEx | $2.45 | +23.3K | 109.8K | +27% | +$57.2K |
| DM | 2021-11-17 | 2021-11-16 | EQ | Zedelmayer Christine | COO, Sr. VP | S - Sale+OE | $5.49 | -11.4K | 94.8K | -11% | -$62.8K |
| DM | 2021-11-17 | 2021-11-16 | EQ | Zedelmayer Christine | COO, Sr. VP | M - OptEx | $0.00 | -23.3K | 75.0K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | M | A | 8,334 | $2.45 | 98,843 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-16 | S | D | 7,350 | $5.49 | 102,409 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $5.59, inclusive. The reporting person undertakes to provide to Equillium, Inc., any security holder of Equillium, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| 3 | Common | Common Stock | 2021-11-16 | M | A | 15,000 | $2.45 | 109,759 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-16 | S | D | 4,084 | $5.49 | 94,759 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.40 to $5.59, inclusive. The reporting person undertakes to provide to Equillium, Inc., any security holder of Equillium, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| 5 | Derivative | Employee Stock Option | 2021-11-16 | M | D | 8,334 | $0.00 | 41,666 | D | $2.45 · 2020-02-13 to 2029-02-12 | 8,334 Common Stock | (F4) In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or expiration dates are not considered to be of the same "class." |
| 6 | Derivative | Employee Stock Option | 2021-11-16 | M | D | 15,000 | $0.00 | 75,000 | D | $2.45 · 2020-12-10 to 2029-12-09 | 15,000 Common Stock | (F4) In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or expiration dates are not considered to be of the same "class." |